
Oklo Inc
Build-own-operate independent power producer: develops Aurora powerhouses, sells electricity + heat via 20+yr PPAs for recurring revenue (analogous to a solar IPP); adjacent radioisotope sales (Atomic Alchemy) and a planned fuel-recycling business. Revenue so far is $3.1M (nine months to Sep 30 2026) of engineering services from two firms acquired in June 2026; first Aurora powerhouse targeted for 2028–2029 (Q3 10-Q).
Sources — 11 figures with citations
- Latest print: Q3 2026 (quarter ended 2026-09-30), reported 2026-11-06filed2026-09-30Revenue $1.861M; operating expenses $84.3M; $11.4M gain on sale of an asset; loss from operations $(71.0)M; net loss $(41.7)M, $(0.22) a sharesec.gov — Recorded Nov 21 2026; figures as the source states them. Oklo filed no results 8-K; the 10-Q is the filed source.
- Cash and securitiesfiled2026-09-30$3,130.8M of cash, equivalents and marketable debt securities plus $81.9M restricted cash; nine-month operating cash use $110.9Msec.gov — Recorded Nov 21 2026; figures as the source states them.
- 2026 guidancefiled2026-11-06Cash used in operations $120–150M; property, plant and equipment purchases $400–500Msec.gov — Recorded Nov 21 2026; figures as the source states them.
- At-the-market programs, nine months 2026filed2026-09-30December 2025 program 12.38M shares, $1,199.9M gross; first 2026 program 17.97M shares, $999.9M; second $1B program (Sep 2026, ongoing) 2,260,556 shares, $88.8M gross at a $39.30 average net pricesec.gov — Recorded Nov 21 2026; figures as the source states them.
- First powerhouse targetfiled2026-11-06'Ambitious target' of 2028–2029 in the Q3 10-Q; 2028 in the Q2 10-Qsec.gov — Recorded Nov 21 2026; figures as the source states them. Q2 wording: https://www.sec.gov/Archives/edgar/data/1849056/000162828026054571/oklo-20260630.htm
- Share price and market capmarket2026-11-20$19.85 at the Nov 20 2026 close; $23.55 on Nov 6 (+22.7% on the report day); market cap $3.88B on 195.29M shares; average target $55.43 from 25 analystsstockanalysis.com — stockanalysis.com, an aggregator; history at https://stockanalysis.com/stocks/oklo/history/
- Watched signal: Aurora-INL DOE steps toward a 2028 startupfiled2026-11-06No final safety analysis reported; the first-powerhouse target is 2028–2029 (Q3 10-Q)sec.gov — Outcome of a signal this entry said to watch; recorded Nov 21 2026.
- Watched signal: NRC application timing and formfiled2026-11-06Still under evaluation, no date; an NRC final rule published 26-Oct-2026, effective 25-Nov-2026, lets applicants use data from DOE-authorized reactors (as the 10-Q describes it)sec.gov — Outcome of a signal this entry said to watch; recorded Nov 21 2026.
- Watched signal: sales under the second $1B programfiled2026-09-302,260,556 shares, $88.8M gross by 30-Sep-2026sec.gov — Outcome of a signal this entry said to watch; recorded Nov 21 2026.
- HALEU supply agreement with Centrusfiled2026-11-11Signed 11-Nov-2026: take-or-pay enrichment deliveries 2029–2031, $35M of prepaymentssec.gov — Recorded Nov 21 2026; figures as the source states them.
- Board falsifier check (state-of-nuclear-energy, state-of-datacenter-power)filed2026-11-06Neither side fired: no binding power purchase agreement and no DOE final safety analysis; second-program sales small ($88.8M); the first-powerhouse target widened to 2028–2029, which leans to the keep-avoid side. Both avoids hold.sec.gov — Recorded Nov 21 2026.
The thesis on this name
State of Data-Center Power
AVOID as a datacenter-power thesis for this horizon (not a high-conviction fundamental short). The build-own-operate microreactor model (sell power, not reactors) has a ~14-18GW pipeline anchored by Switch, Equinix and Meta, April-2026 NRC approval of its design criteria and an upsized 75MWe design, with the first powerhouse targeted for 2028–2029 (Q3 10-Q; 2028 in the Q2 10-Q). Levelized cost guided $40-90/MWh and ~$7,000/kW capex — credible vs NuScale's ~$20,000/kW (fact). But none of that pipeline is a binding power purchase agreement — Meta's 1.2GW Ohio campus rests on a prepayment agreement and Switch's 12GW master agreement is non-binding (fact) — and the build is funded by share sales: about $2.2B in 2026 and a second $1B program opened 11 Sep 2026 (fact; total computed). Real power is years out and execution/licensing risk is high; it stays frontier optionality on the 2028-30 datacenter-nuclear narrative, owned only once a binding contract or Aurora-INL's DOE final safety analysis lands — never as a near-dated toll.
State of Data-Center Power
Avoid: no data-center power before Aurora-INL's 2028–2029 startup target and no binding power purchase agreement yet — Meta's 1.2GW Ohio campus rests on a prepayment agreement and Switch's 12GW on a non-binding master agreement — while the build is funded by repeated share sales.
State of Nuclear Energy
AVOID until the build is contracted and funded (not a high-conviction fundamental short). Oklo is the advanced-fission developer showing real execution — its Groves isotope test reactor went critical on 5 Aug 2026 and DOE approved Aurora-INL's preliminary safety analysis in June 2026 (fact) — and the build-own-operate model means it sells electricity, not reactors: bigger TAM if it works. But the first powerhouse is targeted for 2028–2029 (Q3 10-Q), no power offtake is binding, and the balance sheet ($3,130.8M of cash and securities at Sep 30 2026) rests on share sales — $2.29B gross sold in the nine months, $88.8M of it under the second $1B program (fact; total computed). At ~$3.88B mcap (Nov 20 2026 close) it has no power revenue yet and trades at 1.24x cash per share (computed), so the value above cash is terminal/narrative; the cash floor is being spent at $520-650M a year on 2026 guidance (computed).
State of Nuclear Energy
Avoid: the advanced-fission option is real — Oklo's Groves test reactor went critical on 5 Aug 2026 and Aurora-INL is under construction toward a first-powerhouse target of 2028–2029 — but no power offtake is binding and the build runs on share sales (~$2.2B in 2026, computed; a second $1B program opened 11 Sep 2026).
Earnings, margins, COGS & capex
Oklo is pre-revenue: it books no power or isotope sales (Q3 FY26 revenue was $1.9M of engineering services from acquired firms) and funds its cash burn (Q3 FY26 net loss $41.7M; loss from operations $71.0M after an $11.4M asset-sale gain) from a ~$3.1B war chest raised via equity ($2.29B of it sold in the nine months to Sep 30). The model is capex-heavy upfront (build-own-operate reactors), with recurring PPA cash flow only beginning once the first Aurora reaches commercial operation, targeted for 2028–2029 (Q3 10-Q). Near-term 'value' is regulatory de-risking (April-2026 NRC design-criteria approval, Aurora-INL's preliminary safety analysis approved in June, Groves criticality on 5 Aug 2026) and pipeline conversion, not earnings. The thesis is entirely a function of execution against the licensing and construction timeline.
Income statement — where each revenue dollar goes
% of revenueOf every $1 of revenue, ~97¢ is cost of goods and ~0¢ operating expense, leaving ~3¢ of operating profit (~2¢ net).
Revenue trend
Margins
flat
down (opex rising on headcount + SBC)
down (loss widening YoY)
down
COGS structure
No COGS today — pre-operations. Future cost structure once reactors run: HALEU fuel (metallic U-Zr ~19% enrichment; first cores from recovered EBR-II material via Centrus/DOE), O&M and staffing of each powerhouse, and depreciation of the build-own-operate plant base. As an IPP, gross margin should be high per-MWh once a plant is commissioned (fuel is a small share of nuclear LCOE), but heavy upfront capex makes the model depreciation- and financing-cost-driven. (estimate — no operating history)
Capex
FY26 guidance: $400–500M of capital spending (raised from $350–450M cash used in investing; Q2 FY26 call, per a secondary summary) funding the first Aurora-INL build, the Aurora fuel-fabrication facility at INL, the Aurora-Ohio (Meta 1.2GW) and Aurora-Eielson sites, plus Atomic Alchemy/Groves isotope reactor. Build-own-operate means Oklo carries the plant capex itself rather than selling reactors — capital intensity is structurally high and scales with each fleet addition.
Latest earnings
EPS −$0.22 versus −$0.20 a year earlier and −$0.28 in Q2 (fact; consensus for the quarter was not retrieved). For a pre-revenue developer the print is judged on milestones and cash: 2026 spending guidance held, $3.13B of cash and securities, only $88.8M sold under the second $1B program by Sep 30, and the first-powerhouse target widened to 2028–2029 from 2028. The stock rose 22.7% on the day (stockanalysis.com).
FY2026: cash used in operations $120–150M and property, plant and equipment purchases $400–500M (unchanged, Q3 10-Q). First powerhouse: an 'ambitious target' of 2028–2029 (Q3 10-Q; 2028 in the Q2 10-Q). NRC: Oklo is evaluating the timing and form of future NRC applications while Aurora-INL proceeds under DOE authorization, and gives no application date; an NRC rule effective 25-Nov-2026 lets it draw on DOE-authorized reactor data (10-Q). No binding power purchase agreement.
- Cash + securities
- $3.13B (30-Sep-26)
- Total liabilities
- $120.0M (near debt-free)
- Second $1B program sales
- 2.26M shares, $88.8M gross by 30-Sep-26
- Net loss / EPS
- $41.7M / −$0.22 (Q3 FY26)
Growth drivers
- ~14GW non-binding pipeline conversion to binding PPAs (Switch up to 12GW MPA through 2044; Equinix 500MW with $25M prepay; Meta 1.2GW Ohio campus targeting ~2030)
- NRC licensing progression — April-2026 Principal Design Criteria approval → NRC application (timing and form under evaluation; Aurora-INL runs on DOE authorization) → fleet-replication standard design
- Aurora-INL's remaining DOE steps and first commercial Aurora operations (an 'ambitious target' of 2028–2029 per the Q3 10-Q; 2028 in the Q2 10-Q) — the revenue ignition point; the Groves test reactor went critical on 5-Aug-2026
- Vertical integration into HALEU fuel fabrication + fuel recycling (lower long-run fuel cost, supply security)
- Atomic Alchemy radioisotope sales — a near-term, smaller revenue stream independent of the power timeline (NRC materials license granted Mar-2026)
- AI-datacenter baseload demand secular tailwind (hyperscaler power scarcity, behind-the-meter nuclear interest)
Bull & bear
Oklo is the best-positioned pure-play to monetize AI-datacenter baseload demand: a recurring-revenue IPP model, ~14GW of marquee (non-binding) pipeline, a near-debt-free $3.13B balance sheet (30-Sep-2026), and accelerating DOE regulatory de-risking (Aurora-INL's preliminary safety analysis approved in June; the Groves test reactor critical on 5 Aug) that could ignite isotope revenue in 2027 and first power in 2028–2029. The balance sheet rests on $2.29B of share sales in the nine months to Sep 30, and 2028–2029 is an 'ambitious target' in the company's own words (Q3 10-Q). Checked Nov 21 2026: the funding leg held ($88.8M sold under the second $1B program by Sep 30), but the timeline leg lengthened from 2028 to 2028–2029, with no NRC application date and no binding power purchase agreement.
- Regulatory inflection: April-2026 NRC Principal Design Criteria approval (accelerated), DOE approval of Aurora-INL's Preliminary Documented Safety Analysis (June 2026; two of five DOE steps done) and criticality of the Groves isotope test reactor on 5 Aug 2026 (the first reactor under the DOE pilot program to go critical on private land) materially de-risk the licensing path that killed the 2022 application; Aurora-INL itself still needs its final safety analysis, readiness review and startup authorization
- Demand is real and blue-chip, though none of it is a binding power purchase agreement: Switch (up to 12GW master power agreement to 2044), Equinix (500MW, $25M prepay, non-binding letter of intent), Meta (1.2GW Ohio campus under a prepayment agreement that funds fuel, PJM interconnection filed) — AI power scarcity favors firm baseload
- Build-own-operate yields decades of high-margin PPA cash flow per plant once commissioned, plus optionality from fuel recycling and Atomic Alchemy radioisotopes
- ~$3.0B of cash and marketable securities at 30 Jun 2026 against ~$84M of total liabilities — funds the first reactors without immediate financing distress, though at the raised 2026 guide ($120-150M of operating cash use plus $400-500M of capital spending) the runway is about five years (computed: $3,006M / $585M midpoint)
- Standardized fleet + federal support (DOE loans/pilot, NRC modernization) could compress per-unit cost/time and scale faster than skeptics expect
Oklo is a ~$3.9B (Nov 20 2026 close) pre-revenue developer whose first-of-a-kind power reactor has never operated; the thesis rests on a non-binding pipeline and a multi-year, dilution-funded build ($2.29B of stock sold in the nine months to Sep 30, and a second $1B program open since 11 Sep) where any schedule slip, cost overrun, or licensing setback resets the equity. At $19.85 the stock is 1.24x cash per share ($16.03 at 30 Sep, computed), so about four-fifths of its value is a cash balance that is being spent. Checked Nov 21 2026: schedule risk moved the bear's way, as the Q3 10-Q widened the first-powerhouse target from 2028 to 2028–2029; second-program sales were $88.8M by Sep 30, with ~$911M left to sell.
- Almost no revenue ($1.9M in Q3 FY26, from acquired engineering firms), losses up year on year (Q3 FY26 net loss $41.7M against $29.7M) and first power not before 2028: the Q3 10-Q's 'ambitious target' is 2028–2029, against 2028 in the Q2 10-Q — the timeline is the whole story and it has historically slipped in nuclear
- ~14GW 'pipeline' is non-binding LOIs/MPAs, not contracted revenue; hyperscalers retain full optionality on gas, grid, geothermal, or rival reactors
- Funded by serial dilution ($1.20B under the December 2025 program and $1.00B under the May 2026 program in the nine months to Sep 30; 2.26M shares for $88.8M gross under the second $1B program by Sep 30, whose remaining ~$911M would add ~45.9M shares, ~23%, at $19.85 — computed) — shareholders keep paying for a capex-heavy build with no product yet
- First-of-a-kind execution risk is severe: no Aurora has run, the 2022 NRC application was denied, no total Aurora-INL cost has been given, and FOAK nuclear is the canonical cost/schedule-overrun category
- A risk-off tape raises the cost of dilution and could starve a multi-year build — a textbook 'story stock' on a long fuse; the $23.49 close is 81% below the 52-week high of $123.44, so each share sold raises less capital, and each ~$1B raise at this price adds ~22% to the share count (computed)
What it is worth
Option-value / scenario DCF on risk-adjusted future PPA cash flows (no current earnings or revenue to anchor multiples), so each case is anchored on cash and book value per share ($16.24 computed and $17.34 per the 424B5, at 30-Jun-2026), on the stock's own prices and on analyst targets (aggregator estimates); cross-checked vs listed advanced-nuclear developers on price to net cash per share at the 3-Nov-2026 closes (NANO Nuclear 1.06x and NuScale 2.17x on their 30-Jun-2026 balance sheets; Oklo 1.45x) and on pipeline-GW terms.
~$9.40-16.24/sh
31% to 60% below the $23.49 close: from 1.0x cash per share ($16.24 at 30-Jun-2026, computed), the shallow end, down to about $9.40, roughly the cash left after two more years of spending at the top of the 2026 guide ($650M a year, about $3.4 a share on ~193M shares; computed). NANO Nuclear trades at 1.06x its net cash (3 Nov 2026 close; the cheaper of the two listed developers checked, NuScale at 2.17x), so a price at cash is a de-rating one can point to. The lowest analyst target ($14, aggregator estimate) is 0.86x cash, 40% below the close, and sits inside this range. The June bear ($15-30) contained the close, and its low end sat just below this range's shallow end. Driver: schedule slip / cost overrun / licensing setback or a risk-off capital-markets shock resets the de-rated, dilution-funded story; Aurora-INL slipping past 2028 with no binding offtake. The shallow end holds cash per share at its 30-Jun-2026 level; each year of the $520-650M 2026 spending guide takes about $3 a share off it (computed).
~$23-24/sh
0% vs the $23.49 close: 1.45x cash per share ($16.24 at 30-Jun-2026, computed) and 1.35x net tangible book ($17.34; 424B5), today's multiples held as Aurora-INL construction and DOE authorization grind toward 2028 with no binding offtake and further share sales; NANO Nuclear trades at 1.06x and NuScale at 2.17x their net cash (3 Nov 2026 closes). The June base ($45-75, 'current ~$55 range') sat 92% to 219% above the close, overlaps the bull range, and did not hold. Driver: the market keeps paying a milestone premium over cash with the execution/dilution discount intact.
~$43-65/sh
+81% to +178% vs the $23.49 close: 2.6-4.0x cash per share ($16.24 at 30-Jun-2026, computed). Low end: the 9 Sep 2026 price ($42.57, the last sale before the second at-the-market program opened; 2.6x). High end: the average analyst target ($65.25 = 4.0x; S&P Global, 25 analysts, aggregator estimate). NuScale trades at 2.17x its net cash. The June bull ($120-190+) started level with the Street-high target ($122) and the 52-week high ($123.44) and ran far above both; it did not hold. In June the driver was first reactors on time in 2027-2028; the Q2 10-Q called the 2028 Aurora-INL startup an ambitious target and the Q3 10-Q widened it to 2028–2029, so this case needs the remaining DOE steps cleared on a 2028 schedule, a binding power purchase agreement, and fleet replication scaling.
Worth is the probability-weighted NPV of converting the ~14GW non-binding pipeline (no binding power purchase agreement yet) into operating, owned reactors generating multi-decade PPA cash flow — gated by DOE authorization of Aurora-INL (final safety analysis, readiness review and startup authorization remain, toward a first powerhouse the Q3 10-Q calls an 'ambitious target' for 2028–2029, against 2028 in the Q2 10-Q), NRC application timing, FOAK execution, and dilution; not supportable on any near-term financial metric. Checked Nov 21 2026: at $19.85 the stock is 1.24x cash per share ($16.03 at 30-Sep-2026, computed; 1.45x at the $23.49 Nov 3 close), and the second program's remaining ~$911M would add ~45.9M shares (~23%) at this price (computed); cash per share barely moved, so the case values stand.
SWOT
Strengths
- Fortress balance sheet — ~$3.0B cash/securities at 30 Jun 2026, near debt-free — about five years of runway at the raised FY26 guide of $120-150M operating cash use plus $400-500M capital spending (computed)
- Regulatory momentum — April-2026 NRC Principal Design Criteria approval on an accelerated track (<half normal timeline); DOE pilot-program selection; Aurora-INL's preliminary safety analysis approved in June 2026 and the Groves test reactor critical on 5 Aug 2026
- Differentiated build-own-operate IPP model → recurring multi-decade PPA cash flows vs one-time reactor sales
- Blue-chip non-binding demand — ~14GW pipeline (Switch 12GW, Equinix 500MW, Meta 1.2GW) anchored to AI-datacenter baseload need
- Vertical integration — in-house HALEU fuel fab + fuel recycling + Atomic Alchemy radioisotopes diversify beyond power
Weaknesses
- Almost no revenue ($1.9M in Q3 FY26, from acquired engineering firms) and a $41.7M quarterly net loss — entirely pre-commercial; first power not before 2028, with the company's target at 2028–2029
- Heavy, recurring equity dilution (~$1.18B ATM in Q1 FY26, about $1.0B more under the May program, and a second $1B program open since 11 Sep) funds the build-own-operate capex
- Execution risk on a first-of-a-kind reactor — no Aurora has ever operated; 2022 NRC application was previously denied
- Pipeline is non-binding LOIs/MPAs, not contracted revenue — convertibility unproven
- Valuation (~$3.88B at the Nov 20 2026 close) is 1.24x cash per share ($16.03 at 30 Sep 2026, computed) while the cash is spent at $520-650M a year (2026 guide); no near-term financial anchor under the rest
Opportunities
- AI/datacenter power scarcity could pull forward binding behind-the-meter nuclear PPAs at premium prices
- Fleet standardization (one approved design replicated) compresses cost/time per incremental reactor
- Radioisotope market (cited ~$55.7B by 2026) gives an earlier, smaller revenue path via Atomic Alchemy; the 10-Q expects the first isotope revenue from its Abundantia project in 2027
- Federal tailwinds: DOE loans/pilot program, NRC licensing modernization, pro-nuclear policy
- Fuel recycling (closing the fuel cycle) is a long-run cost + national-security moat if it works at scale
Threats
- Schedule slip / cost overrun on first reactor — the classic nuclear-project risk — would reset the thesis
- Competing SMR designs further along — NuScale has NRC design approval, and four other DOE pilot-program reactors (Antares, Valar, Deployable Energy, Aalo) reached criticality before the 4 Jul goal, ahead of Oklo's Groves (5 Aug)
- Customer optionality: hyperscalers may favor gas, geothermal, grid PPAs, or rival reactors if Oklo slips
- Capital-markets dependence — a risk-off / rate shock raises dilution cost and could starve the build; the $23.49 close is 81% below the 52-week high, so each share sold raises less capital
- HALEU/fuel supply-chain constraints (enrichment capacity, recovered-material logistics) gating deployment
Moats, dependencies & bottlenecks
Moats
Medium-high once a design is approved April-2026 NRC Principal Design Criteria approval + DOE pilot selection are real barriers, but design approval ≠ a built/operating plant, and rivals (NuScale) hold NRC design approval too. Moat widens sharply only after fleet COLA approval + first operation.
if contracts go binding 20-44yr PPAs (Switch to 2044) create durable switching costs — but today they are non-binding; the moat is prospective, not yet realized.
if it works at scale In-house fuel fabrication and closing the fuel cycle could lower long-run cost and lock supply in a constrained HALEU market — unproven commercially.
Marquee anchors (Switch, Equinix, Meta) + NVIDIA/LANL collaboration give brand and demand visibility, but relationships are early and non-exclusive.
$3.0B near-debt-free balance sheet (30-Jun-2026) lets it self-fund first reactors — an advantage over thinner-capitalized SMR peers, but contingent on capital-markets access.
Dependencies
Commercial deployment beyond DOE-authorized projects needs NRC licensing, and Oklo says it is still evaluating the timing and form of its applications (10-Q) while Aurora-INL runs on DOE authorization; the 2022 application was denied, so this stays a gating dependency for the fleet.
DOE/EBR-II recovered material, fuel-fab facility) First cores depend on scarce ~19%-enriched HALEU and the not-yet-operating Aurora fuel-fab facility; enrichment/logistics constraints can gate deployment.
Equinix, Meta) The entire revenue thesis rests on non-binding pipeline becoming contracted offtake; hyperscalers retain optionality.
Build-own-operate capex is funded by dilution (~$2.2B sold in 2026, a second $1B program open since 11-Sep-2026); a risk-off shock raises cost of capital and could starve the build.
No Aurora has been built or operated; FOAK nuclear is the canonical cost/schedule-overrun risk.
Advantages
- Near-debt-free $3.0B cash/securities — about five years of runway at the 2026 spending guide (computed) and self-funded first reactors (30-Jun-2026)
- Accelerated NRC design-criteria approval + DOE pilot-program selection — ahead of most non-NuScale SMR peers on real federal traction
- ~14GW of marquee, AI-datacenter-anchored demand visibility (Switch/Equinix/Meta) few competitors can match
- Recurring-revenue IPP model (own + operate) captures decades of margin per plant vs one-time reactor sales
- Optionality beyond power — Atomic Alchemy radioisotopes (NRC materials license, near-term sales) + fuel recycling
- High-profile ecosystem (NVIDIA/LANL fuel-AI collaboration, Sam Altman chairman legacy) aiding capital access and mindshare
Weaknesses
- Almost no revenue ($1.9M in Q3 FY26, from acquired engineering firms); first commercial operations not until 2028–2029 on the company's target — long fuse
- Losses ($41.7M net loss in Q3 FY26, after $48.5M in Q2 FY26) and ongoing, large shareholder dilution
- First-of-a-kind reactor never built or operated; prior 2022 NRC application denied
- Pipeline is non-binding — no contracted, recognized revenue backlog
- Valuation (~$3.88B at the Nov 20 2026 close) is 1.24x cash per share ($16.03 at 30 Sep 2026, computed) while the cash is spent at $520–650M a year (2026 guide), leaving little margin for the schedule slips endemic to nuclear builds
- Heavy dependence on external capital + on HALEU fuel and fuel-fab readiness it doesn't yet fully control
Bottlenecks
- DOE authorization steps for Aurora-INL (final documented safety analysis, readiness review, startup authorization), NRC licensing for later plants, and the per-site licensing/siting + environmental review cadence
- HALEU fuel availability and the still-to-be-commissioned Aurora fuel-fabrication facility
- First-of-a-kind construction — supply chain, skilled nuclear labor, and schedule for the inaugural Aurora-INL build
- Grid interconnection / site permitting (e.g. PJM interconnection queue for the Meta-Ohio 1.2GW campus)
- Capital intensity — each owned plant requires large upfront capex funded ahead of any cash flow
Top signals & trends
Top signals
Funding held and second-program sales were small ($88.8M gross by Sep 30), but the 10-Q moved the first-powerhouse target from 2028 to 2028–2029 and gives no NRC application date; after the quarter Oklo signed a HALEU supply agreement with Centrus for 2029–2031 deliveries ($35M of prepayments; 8-K, Nov 17). The stock rose 22.7% on the report day and closed at $19.85 on Nov 20 (stockanalysis.com). The analysis text is as of the entry's stated date and predates the print unless dated otherwise.
Groves reached criticality on 5 Aug 2026, after four other pilot reactors met the 4 Jul goal; the Q3 10-Q states the first-powerhouse target as 2028–2029 (2028 in the Q2 10-Q), with two of five DOE steps done. Clearing the final safety analysis on schedule is the next de-risking event; a slip past 2028 is a major negative tell, and the widened target meets it in part (no slip past 2028 is confirmed).
Oklo says it is evaluating the timing and form of future NRC applications (10-Q) while Aurora-INL runs on DOE authorization; the NRC approved the design-criteria report in April 2026. An accepted application would be the gate to commercial licensing.
None is binding yet: Meta's 1.2GW Ohio campus rests on a prepayment agreement, Switch's 12GW on a master power agreement, and Equinix, Diamondback and Prometheus on non-binding letters of intent (10-Q); a binding, priced PPA is the proof the demand is real and bankable.
An early, smaller revenue stream independent of the multi-year power timeline: the 10-Q expects the first isotope revenue from the Abundantia project in 2027; Q3's $1.9M of revenue is engineering services.
The company has not given a total Aurora-INL cost, and the Q3 10-Q widened its 'ambitious target' for the first powerhouse from 2028 to 2028–2029; FOAK nuclear overruns are the canonical failure mode and a further slip would reset the timeline thesis.
The company has not given a total Aurora-INL cost and calls the 2028 startup an 'ambitious target'; FOAK nuclear overruns are the canonical failure mode and a first slip would reset the timeline thesis.
Trends
Core demand tailwind — firm, 24/7, carbon-free power is exactly what AI campuses need; underpins the Switch/Equinix/Meta pipeline.
Accelerated PDC approval (<half normal timeline) shows the regulatory path is genuinely speeding up for advanced reactors.
Necessary enabler but currently constrained; supply ramp is both a tailwind and a bottleneck.
Abundant investor interest funds the build but inflates valuations and invites competition (NuScale, NANO, X-energy, TerraPower, Kairos).
Favors modular, sited-at-load reactors over grid-dependent supply — structurally suits Oklo's powerhouse model.
Supports the Atomic Alchemy adjacency as an earlier, policy-favored revenue path.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
HALEU enrichment/fuel-supply partner — critical for ~19%-enriched fuel; also a JV partner.
Department of Energy / Idaho National Laboratory Host site (INL), DOE pilot-program sponsor, and source of recovered EBR-II HALEU material for first cores.
Partner on plutonium-bearing fuel validation (with NVIDIA) under the DOE pilot program.
Partner to develop US nuclear fuel-fabrication infrastructure.
Datacenter power/cooling-infrastructure collaborator for integrating reactors with AI campuses.
Energy-services partner referenced in datacenter-power buildout collaboration.
Non-binding Master Power Agreement for up to 12GW through 2044 — the anchor of the pipeline.
500MW agreement with a $25M prepayment for a 20-year PPA.
1.2GW Aurora-Ohio campus (PJM interconnection filed), targeted ~2030.
Aurora-Eielson microreactor project — government/defense baseload customer.
Healthcare / research / defense isotope buyers End markets for Atomic Alchemy radioisotopes (large cited market opportunity).
Closest US-listed SMR peer; holds NRC Standard Design Approval (77MWe module) — ahead of Oklo on certified design, lighter on datacenter pipeline. Light-water vs Oklo's fast-spectrum.
Microreactor developer (KRONOS MMR ~15MWe; CPA submitted Apr-2026) with its own HALEU fuel subsidiary; earlier-stage but overlapping microreactor niche.
Gates-backed sodium-fast reactor (345MWe) under construction in Wyoming; technically closest analog, larger scale, well-capitalized — a direct fast-reactor rival.
HTGR developer with Amazon/DOE backing and datacenter ambitions; competes for the same hyperscaler offtake.
Fluoride-salt-cooled reactor with a Google PPA and NRC construction permits in hand — a credible datacenter-nuclear competitor.
Incumbent large-reactor operators already signing datacenter PPAs (e.g. restarts, uprates) — the 'available now' alternative to waiting for SMRs.